Education
About Us
Working with TipRanks
Follow Us
MaxCyte Inc (MXCT)
NASDAQ:MXCT
Total Valuation
MaxCyte has a market cap or net worth of £233.90M. The enterprise value is $169.80M.
Market Cap£233.90M
Enterprise Value$169.80M
Share Statistics
MaxCyte has 106,318,535 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding106,318,535
Owned by Insiders0.68%
Owned by Institutions30.94%
Financial Efficiency
MaxCyte’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -22.80%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-22.80%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee338.83K
Profits Per Employee-360.13K
Employee Count114
Asset Turnover0.16
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of MaxCyte is ―. MaxCyte’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.11
Price to FCF0.00
Price to Operating Cash Flow-7.54
PEG Ratio―
Income Statement
In the last 12 months, MaxCyte had revenue of 38.63M and earned -41.05M in profits. Earnings per share was -0.39.
Revenue38.63M
Gross Profit31.53M
Operating Income-51.20M
Pretax Income-41.05M
Net Income-41.05M
EBITDA-46.41M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was -31.46M and capital expenditures -1.50M, giving a free cash flow of -32.96M billion.
Operating Cash Flow-31.46M
Free Cash Flow-32.96M
Free Cash Flow per Share-0.31
Dividends & Yields
MaxCyte pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change-52.07%
50-Day Moving Average2.21
200-Day Moving Average3.22
Relative Strength Index (RSI)43.40
Average Volume (3m)1.04M
Important Dates
MaxCyte upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MaxCyte as a current ratio of 10.88, with Debt / Equity ratio of 9.44%
Current Ratio10.88
Quick Ratio10.32
Debt to Market Cap<0.01
Net Debt to EBITDA0.21
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MaxCyte has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MaxCyte EV to EBITDA ratio is -9.19, with an EV/FCF ratio of -14.57.
EV to Sales11.04
EV to EBITDA-9.19
EV to Free Cash Flow-14.57
EV to Operating Cash Flow-15.44
Balance Sheet
MaxCyte has £23.39M in cash and marketable securities with £18.82M in debt, giving a net cash position of -£4.56M billion.
Cash & Marketable Securities£23.39M
Total Debt£18.82M
Net Cash-£4.56M
Net Cash Per Share-£0.04
Tangible Book Value Per Share£1.97
Margins
Gross margin is 78.16%, with operating margin of -132.54%, and net profit margin of -106.29%.
Gross Margin78.16%
Operating Margin-132.54%
Pretax Margin-106.29%
Net Profit Margin-106.29%
EBITDA Margin-120.14%
EBIT Margin-132.54%
Analyst Forecast
The average price target for MaxCyte is £6.77, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target£6.77
Price Target Upside232.08% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast-14.48%
EPS Growth Forecast-12.34%